View in EDS HTML Full Text PDF Full Text

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

Saved in:
Bibliographic Details
Title: A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Authors: López-Guillermo, Armando1 (AUTHOR), Canales, Miguel Ángel2 (AUTHOR), Dlouhy, Ivan1 (AUTHOR), Mercadal, Santiago3 (AUTHOR), Briones, Javier4 (AUTHOR), Martín García-Sancho, Alejandro5 (AUTHOR), Sancho, Juan Manuel6 (AUTHOR), Moraleda, José María7 (AUTHOR), Terol, María José8 (AUTHOR), Salar, Antonio9 (AUTHOR), Palomera, Luis10 (AUTHOR), Gardella, Santiago1,11 (AUTHOR), Jarque, Isidro12 (AUTHOR), Ferrer, Secundino13 (AUTHOR), Bargay, Joan14 (AUTHOR), López, Andrés15 (AUTHOR), Panizo, Carlos16 (AUTHOR), Muntañola, Anna17 (AUTHOR), Montalbán, Carlos18 (AUTHOR), Conde, Eulogio19 (AUTHOR)
Source: Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p93-100. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2021.1971216